[Pharmacological properties of the products of condensation of phenamine with some metabolites].
D062365:Aminobenzoates / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D006582:Hexachlorophene / Q000494:pharmacology; D051379:Mice; D009536:Niacinamide / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012702:Serotonin Antagonists; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D062365:Aminobenzoates; D000613:Aminobutyrates; D000959:Antihypertensive Agents; D011725:Pyridines; D012702:Serotonin Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D009536:Niacinamide; D000661:Amphetamine; D006582:Hexachlorophene
Farmakologicheskie svoĭstva produktov kondensatsii fenamina s nekotorymi metabolitami.